Denosumab is a monoclonal antibody used to treat osteoporosis and other bone-related conditions. It works by inhibiting a protein called RANKL, which plays a key role in the formation, function, and survival of osteoclasts, the cells responsible for bone resorption. Denosumab is available under the brand names Prolia and Xgeva.
